Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001401312-10-000005
Filing Date
2010-06-03
Accepted
2010-06-03 13:47:51
Documents
1
Period of Report
2010-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3239
  Complete submission text file 0001401312-10-000005.txt   5331
Mailing Address 927 CANADA CT. CITY OF INDUSTRY CA 91748
Business Address 927 CANADA CT. CITY OF INDUSTRY CA 91748 626-581-9098
China Yongxin Pharmaceuticals Inc. (Issuer) CIK: 0001087848 (see all company filings)

EIN.: 880420306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries

Mailing Address C/O DELCATH SYSTEMS, INC. 600 FIFTH AVENUE NEW YORK NY 10020
Business Address
Philips Laura A (Reporting) CIK: 0001401312 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26293 | Film No.: 10875333